Edal, Rey L.

HRN: 29-21-15  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/22/2026
CEFTRIAXONE 1G (VIAL)
06/22/2026
06/29/2026
IV
1.2 GRAM
Q12HRS
T/C SEPSIS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  BloodstreamSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines